SalioGen's Gene Coding Therapy is Invested in by the CF FoundationThe Cystic Fibrosis Foundation has announced an investment in SalioGen Therapeutics to support the companyҳ preclinical research toward थveloping..#Cystic Fibrosis·disorders.solutions·Jan 10, 2022SalioGen's Gene Coding Therapy is Invested in by the CF Foundation